SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending downwards as investors react to Michael Burry's reported short position and concerns about the stock's high valuation despite strong earnings and raised guidance; the community is debating whether this is a buying opportunity or a sign of an AI bubble, while also scrutinizing CEO Alex Karp's response to the short sellers.

Hertz Global Holdings, Inc. engages in the vehicle rental business through the Hertz, Dollar, and Thrifty brands. It operates under the Americas Rental Car (RAC) and International Rental Car (RAC) segments. The Americas RAC segment focuses on operations in the United States, Canada, Latin America, and the Caribbean. The International RAC segment includes the provision of rental and sales of vehicles and value-added services in other locations. The company was founded in 1918 and is headquartered in Estero, FL.

Hertz Global Holdings Inc. - Ordinary Shares (New)

Hertz ($HTZ) is trending following news of a partnership with Amazon and a debt offering, sparking significant price movement. The community is discussing a potential short squeeze, drawing comparisons to other meme stocks and highlighting high short interest. Bullish sentiment revolves around the company's turnaround and potential for further gains.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with Mobility Drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, or taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting Carriers with Shippers on its platform, and gives Carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Uber is trending amidst strong Q3 earnings results, with community chatter focusing on revenue and bookings growth, and potential for future gains. Despite positive reports, some express concern over operating profit margins and overall market conditions impacting the stock's performance. Discussions also highlight Uber's moves in autonomous vehicles and partnerships as long-term growth catalysts.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as investors debate its current valuation and future prospects ahead of earnings. Community chatter revolves around recent price drops, potential market manipulation, and the impact of prediction markets on the company's core business. Some are optimistic about a potential earnings beat and long-term growth in the sports betting market, while others express concerns about competition and overall market sentiment.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer's Q3 earnings beat and raised EPS guidance are overshadowed by discussions around its pursuit of Metsera, with a potential bidding war against Novo Nordisk capturing community attention. Community sentiment is mixed, with some questioning the company's strategy and others focusing on the dividend yield and long-term potential. The conversations also highlight the broader competition in the weight-loss drug market and potential acquisitions.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Despite reporting record revenue, Norwegian Cruise Line's stock is trending downward, with community members pointing to a revenue miss and the company's debt as potential factors. Investors are actively discussing management's performance and the stock's valuation compared to its peers in the consumer sector. Some traders believe the stock is being manipulated and are looking for short-term opportunities.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending due to an ongoing bidding war with Pfizer for Metsera, with a judge initially hesitant to intervene. The community is discussing the potential implications of this acquisition, its impact on competition in the weight loss drug market, and speculation around Medicare coverage for obesity drugs following a potential deal with the White House. Some investors express frustration with the stock's recent performance amid these developments.

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is facing downward pressure, sparking debate about whether the bull run is over as it approaches the critical $100,000 level. Community discussions revolve around potential support levels and whether to "buy the dip" or brace for a deeper correction. Some traders speculate on market manipulation and the influence of institutional investors, while others point to broader macroeconomic factors and historical patterns.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals is trending following positive analyst updates and price target increases, with UBS setting a target of $38. The community is weighing revenue multiples against peers, considering potential M&A activity, especially by Incyte, and debating the impact of recent earnings and approval news on the stock's valuation. Discussions also include bullish sentiment and the potential for a short squeeze.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending amid speculation of a potential acquisition driven by a bidding war for a competitor, Metsera, highlighting the value of obesity and MASH assets. The community is actively discussing potential buyout prices, partnership opportunities, and the competitive landscape, with some emphasizing VKTX's strong position and promising clinical data. Concerns about dilution and competition from larger pharmaceutical companies are also being debated.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Norwegian Cruise Line (NCLH) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Norwegian Cruise Line (NCLH) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Norwegian Cruise Line (NCLH) Tops Q3 Earnings Estimates

Norwegian Cruise Line (NCLH) delivered earnings and revenue surprises of +3.45% and -2.60%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Airbnb Set to Report Q3 Earnings: What's in the Cards for the Stock?

ABNB's Q3 results may reflect stronger bookings, rising ADR and AI-driven service gains, despite margin pressure from higher investments.


SNAP Gears Up to Report Q3 Earnings: What's in Store for the Stock?

Snap faces Q3 headwinds from ad pricing pressure and soft North America trends, but global user growth may offer support.

Unity Software to Post Q3 Earnings: What's in Store for the Stock?

U eyes Q3 growth with Vector AI gains and ad momentum, but mixed signals from Create Solutions may weigh on results.

Norwegian Cruise to Post Q3 Earnings: What's in the Cards?

NCLH is set to report Q3 results, driven by strong demand, luxury segment growth and solid onboard spending.

Norwegian Cruise Line Holdings Ltd. (NCLH) is Attracting Investor Attention: Here is What You Should Know  

Zacks.com users have recently been watching Norwegian Cruise Line (NCLH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Royal Caribbean Q3 Earnings Sail Higher on Robust Bookings & Yield

RCL's third-quarter profit cruised past expectations as robust bookings, strong yields and digital momentum powered record guest satisfaction.

Earnings Preview: AMC Entertainment (AMC) Q3 Earnings Expected to Decline

AMC Entertainment (AMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Norwegian Cruise Line (NCLH) Stock Sinks As Market Gains: What You Should Know

Norwegian Cruise Line (NCLH) concluded the recent trading session at $22.35, signifying a -4.93% move from its prior day's close.

Buying

Selling or Trimming

Holding

Watching from the sidelines

What are you doing with $PLTR stock on the post-earnings sell-off?

NCLH
Norwegian Cruise Line Holdings Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest NCLH News

NCLHNorwegian Cruise Line Holdings Ltd